Kezar Life Sciences Inc (KZR)

Shares of Kezar Life Sciences are up an astounding 74% today after the biotechnology company reported positive results from its clinical trial regarding a treatment for the autoimmune disease Lupus.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 28, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning!

Billionaire Israel Englander Is Betting Big on These 5 Stocks

By Eddie Pan, InvestorPlace Financial News Writer Jun 24, 2022

Millennium Management's Israel Englander is in focus after the billionaire's fund purchased several stocks this month.

3 Biotech Stocks to Buy Before They Boom

By Shanthi Rexaline Jun 1, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Nov 16, 2021

Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday.

Kezar Life Sciences names new CEO, says to cut workforce by about 41% (NASDAQ:KZR)

From Seeking Alpha Oct 3, 2023

Kezar Life Sciences (KZR) on Tuesday announced a strategic restructuring, including the reduction of its workforce by about 41%. Read more here.

RGEN, BGCP and TLS are among after hour movers (NASDAQ:KZR)

From Seeking Alpha Jun 16, 2023

Gainers: Kezar Life Sciences (KZR) +6%. Telos Corporation (TLS) +4%

KZR stock falls after R&D event as William Blair downgrades (NASDAQ:KZR)

From Seeking Alpha Mar 16, 2023

Kezar Life Sciences (KZR) lost ~14% on Thursday morning after William Blair downgraded it following management comments at at the company’s R&D event yesterday. Read the full story here.

(NASDAQ:KZR)

From Seeking Alpha Mar 14, 2023

Kezar Life Sciences press release (KZR): Q4 GAAP EPS of -$0.25 beats by $0.03.Cash, cash equivalents and marketable securities totaled $276.6 million as of December 31, 2022

Analysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)

From TipRanks Nov 11, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kezar Life Sciences (

Kezar Life Sciences GAAP EPS of -$0.25 (NASDAQ:KZR)

From Seeking Alpha Nov 10, 2022

Kezar Life Sciences press release (KZR): Q3 GAAP EPS of -$0.25.Cash, cash equivalents and marketable securities totaled $290.4 million as of September 30, 2022, compared to $208.4...

Kezar Life Sciences Inc (KZR)

From Pennies to Fortunes: 3 Stocks Set to Make Millionaires

Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026

KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Kezar Life Sciences Inc (KZR)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

KZR Stock Predictions, Articles, and Kezar Life Sciences Inc News

Subscriber Sign in